China Health Industries Holdings Inc (CHHE) Inventory Turnover Ratio, from third quarter 2024 to third quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
China Health Industries Holdings Inc   (NONE: CHHE)
 

China Health Industries Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

China Health Industries Holdings Inc inventory turnover ratio, the China Health Industries Holdings Inc 's ability to sell and replace its inventory in the third quarter 2024, sequentially increased to 8.48 in the third quarter 2024, yet the ratio remained below the average, as CHHE's market remain challenging.Average inventory processing period, for the China Health Industries Holdings Inc in Mar 31 2024 quarter, has decreased to 43 days, compare to 338 days, in the Dec 31 2023 quarter.

Within Healthcare sector 42 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2024, to 400, from total ranking in the second quarter 2024 at 1404.

CHHE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is China Health Industries Holdings Inc Market Share?

What is Inventory Turnover Ratio?




CHHE Inventory Turnover Ratio (Mar 31 2024)
III. Quarter
(Dec 31 2023)
II. Quarter
(Sep 30 2023)
I. Quarter
(Jun 30 2023)
IV. Quarter
(Mar 31 2023)
III. Quarter
Y / Y Inventory Growth -99.41 % -99.43 % -99.5 % -92.21 % -53.67 %
Y / Y Cost of Sales Growth -99.54 % -99.84 % -0.52 % 3012.87 % 272514.29 %
Inventory Turnover Ratio (TTM) 8.48 1.08 0.69 0.45 0.2
CHHE's Total Ranking # 400 # 1404 # 1622 # 2037 # 1722
Average inventory processing period 43 338 525 809 1850
Seq. Inventory Growth -1.59 % 2.66 % -94.26 % -89.83 % -4.83 %
Seq. Cost of Sales Growth 89.13 % -99.88 % -38.85 % 228.2 % -35.63 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 14
Healthcare Sector # 43
Overall Market # 400

Inventory Turnover Ratio Statistics
High Average Low
136.45 19.99 0.01
(Sep 30 2013)   (Jun 30 2022)




Financial Statements
China Health Industries Holdings Inc 's Inventories $ 0 Millions Visit CHHE's Balance sheet
China Health Industries Holdings Inc 's Cost of Revenues TTM $ 0 Millions Visit CHHE's Income Statement
What are CHHE's Sales? Visit CHHE's Sales by Segment

Other Inventory Turnover Ratios
China Health Industries Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CHHE's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CHHE's Competitors
Inventory Turnover Ratio for CHHE's Suppliers
Inventory Turnover Ratio for CHHE's Customers

You may also want to know
CHHE's Sales Growth Rates CHHE's Pe Price to earnings ratio CHHE's Receivables Turnover Ratio CHHE's Stock Quote
CHHE's Net Income Growth Rates CHHE's Ps Price to Sales ratio CHHE's Sales per Employee CHHE's Asset Turnover Ratio
CHHE's Net Margin CHHE's Pb Price to Book ratio CHHE's Financial Strength Ratios CHHE's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2024 Inventories at quarter ending Mar 31 2024
Healthcare Services Group Inc   77.19 $ 1,460.603  Millions$ 19  Millions
Quest Diagnostics Inc  33.74 $ 6,234.000  Millions$ 185  Millions
Adapthealth Corp   24.18 $ 2,740.910  Millions$ 113  Millions
Harmony Biosciences Holdings inc   24.05 $ 127.220  Millions$ 5  Millions
Earth Science Tech Inc   23.23 $ 3.712  Millions$ 0  Millions
Teladoc Health Inc   23.21 $ 764.462  Millions$ 33  Millions
Vaso Corporation  20.59 $ 30.740  Millions$ 1  Millions
Qhslab Inc   19.17 $ 0.652  Millions$ 0  Millions
Aurinia Pharmaceuticals Inc   19.16 $ 21.479  Millions$ 1  Millions
Precipio inc   18.43 $ 9.623  Millions$ 1  Millions
Labcorp Holdings Inc   17.43 $ 8,272.800  Millions$ 475  Millions
Bespoke Extracts Inc  17.01 $ 0.521  Millions$ 0  Millions
Viemed Healthcare Inc   16.66 $ 75.464  Millions$ 5  Millions
Semler Scientific inc   15.75 $ 6.962  Millions$ 0  Millions
The Oncology Institute Inc   15.15 $ 187.700  Millions$ 12  Millions
Aspira Women s Health inc   14.31 $ 3.706  Millions$ 0  Millions
Natera Inc   14.19 $ 597.814  Millions$ 42  Millions
Option Care Health Inc   13.36 $ 3,441.157  Millions$ 258  Millions
Acadia Pharmaceuticals Inc   13.33 $ 62.922  Millions$ 5  Millions
Rockwell Medical inc   13.12 $ 76.223  Millions$ 6  Millions
Opko Health Inc   12.99 $ 869.844  Millions$ 67  Millions
Bioaffinity Technologies Inc   12.67 $ 0.152  Millions$ 0  Millions
Intelgenx Technologies Corp   12.44 $ 1.269  Millions$ 0  Millions
Irhythm Holdings Inc   11.81 $ 168.245  Millions$ 14  Millions
Sunlink Health Systems Inc   11.55 $ 18.800  Millions$ 2  Millions
Dermtech Inc   11.39 $ 12.484  Millions$ 1  Millions
Vanda Pharmaceuticals Inc   10.88 $ 13.462  Millions$ 1  Millions
Sotera Health Company  10.77 $ 483.913  Millions$ 45  Millions
Agile Therapeutics Inc  10.67 $ 30.497  Millions$ 3  Millions
Genedx Holdings Corp   10.57 $ 109.097  Millions$ 10  Millions

Date modified: 2026-09-08T15:11:17+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.